Summit Global Investments Purchases New Shares in Castle Biosciences, Inc. (NASDAQ:CSTL)

Summit Global Investments purchased a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 23,812 shares of the company’s stock, valued at approximately $518,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CSTL. RiverPark […]

Leave a Reply

Your email address will not be published.

Previous post 3M (NYSE:MMM) Trading Up 0.8%
Next post Summit Global Investments Buys New Position in Lululemon Athletica Inc. (NASDAQ:LULU)